News

Duke HIV scientist searches for funding after Trump ends landmark vaccine center
In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...
Healio5d
HIV funding cuts threaten to undo decades of progress
Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of ...
WHO Extended Global Emergency Status of MPox Epidemic – Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
allAfrica.com on MSN1d
SA gets R520m to buy the twice-a-year anti-HIV jab... but there’s a snag
South Africa has accepted an offer of just over $29 million (about R520 million) from the Global Fund to Fight Aids, TB and ...
The Mail & Guardian8h
SA gets R520 million to buy the twice-a-year anti-HIV jab – but there’s a snag
The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it ...
LoveBScott on MSN46m
Why 'I Don't Need PrEP' Mindset Might Be A Riskier Than You Think
For some people, HIV feels like something that happens to “other people.” It’s a distant issue — something for a different ...
Bhekisisa1d
BREAKING: SA gets R520-million to buy the twice-a-year anti-HIV jab — but there’s a snag
SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...
An FDA-approved drug halts Epstein-Barr virus-driven lymphoma by disrupting a key cancer pathway
Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can ...
Adaptive Clinical Protocol Design for Phase II MPox Clade I Treatment with a Novel Broad-Spectrum Drug NV-387 is Almost Complete, Reports NanoViricides
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
University of California, San Francisco1d
UCSF Community Mourns the Loss of William J. Rutter (1928 – 2025)
The UCSF community is saddened at the passing of former UCSF faculty member William Rutter, PhD, whose collaborative and ...
Clinical Trials Arena3h
PEPFAR funding protection offers “hope” for people living with HIV
The White House’s decision to safeguard $400m in President’s Emergency Plan for AIDS Relief (PEPFAR) funding to support the global human immunodeficiency virus (HIV) emergency provides “hope” to ...